AKT1 and colitis: Since the PI3K/AKT and NF-κB signaling pathways play essential roles in colitis [25–28], we next determined the effect of dihydroartemisinin on the PI3K/AKT and NF-κB signaling pathways in colitis both in vivo and in vitro.